Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose intravenous vitamin C in castration-resistant metastatic prostate cancer
2008-008692-33Phase 2Completed
- Sponsor
- Department of Urology, Herlev Hospital
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ascorbic acid in prostate cancer (PCa), sponsored by Department of Urology, Herlev Hospital. Primary endpoint: PSA response to high-dose intravenous vitamin C. Started Dec 2009; status: completed.
02
Drugs
ascorbic acid
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2008-008692-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008692-33.